Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06961604 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Novel Method for Determination of Thromboembolic Stroke Origin

StatusNot Yet Recruiting
PhaseEarly Phase 1
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated May 8, 2025 (before its estimated June 1, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
Rupture of vulnerable carotid, vertebral, and intracranial arterial plaques results in thromboembolic stroke. Identification of these culprit lesions is an important component of post-stroke care. This study seeks to test the feasibility of NaF PET-CT to detect these plaques and alter patient care. Prior studies have shown a high degree of correlation between NaF PET+ lesions and high-risk plaque features on high resolution MRI, including mirocalcification, necrosis, and ulceration.
Trial Details
NCT Number NCT06961604
Lead Sponsor Atlantic Health System
Conditions
(from sponsor)		 Thromboembolic Stroke
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov